May 02, 2019 review Myasthenia gravis Nature Reviews Disease Primers DOI: 10.1038/s41572-019-0079-y OpenAlex Authors 0 Author list not loaded yet. Cited by 22 stored of 953 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Long-term safety, tolerability, and efficacy of subcutaneous efgartigimod PH20 in generalized myasthenia gravis: final results from a phase 3 open-label extension study (ADAPT-SC+) 2026 Frontiers in Neurology article Medicine Myasthenia Gravis and Thymoma Open access 0 citations A Delphi consensus on integrating novel therapies into the management of generalized myasthenia gravis 2026 Therapeutic Advances in Neurological Disorders article Medicine Myasthenia Gravis and Thymoma Open access 0 citations Correlation of C-Reactive Protein With Severe Fatigue in Patients With Myasthenia Gravis 2025 Neurology Neuroimmunology & Neuroinflammation article Medicine Myasthenia Gravis and Thymoma Open access 4 citations Toward European harmonization of national myasthenia gravis registries: modified Delphi procedure-based expert consensus on collectable data 2025 Orphanet Journal of Rare Diseases article Medicine Myasthenia Gravis and Thymoma Open access 4 citations 275th ENMC international workshop: Seronegative myasthenia gravis: An update paradigm for diagnosis and management, 9–11 February 2024, Hoofddorp, the Netherlands 2024 Neuromuscular Disorders article Medicine Myasthenia Gravis and Thymoma Open access 16 citations Agonist antibody to MuSK protects mice from MuSK myasthenia gravis 2024 Proceedings of the National Academy of Sciences article Medicine Myasthenia Gravis and Thymoma Open access 20 citations The ClC-1 chloride channel inhibitor NMD670 improves skeletal muscle function in rat models and patients with myasthenia gravis 2024 Science Translational Medicine article Medicine Myasthenia Gravis and Thymoma Open access 33 citations Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis 2024 Frontiers in Neurology article Medicine Myasthenia Gravis and Thymoma Open access 87 citations Myasthenia gravis—Pathophysiology, diagnosis, and treatment 2024 Handbook of clinical neurology book-chapter Medicine Myasthenia Gravis and Thymoma 50 citations Assessing facial weakness in myasthenia gravis with facial recognition software and deep learning 2023 Annals of Clinical and Translational Neurology article Medicine Myasthenia Gravis and Thymoma Open access 22 citations Eye Muscle MRI in Myasthenia Gravis and Other Neuromuscular Disorders 2023 Journal of Neuromuscular Diseases article Medicine Myasthenia Gravis and Thymoma Open access 9 citations Efgartigimod improved health-related quality of life in generalized myasthenia gravis: results from a randomized, double-blind, placebo-controlled, phase 3 study (ADAPT) 2023 Journal of Neurology article Medicine Myasthenia Gravis and Thymoma Open access 57 citations Diagnosing myasthenia gravis using orthoptic measurements: assessing extraocular muscle fatiguability 2022 Journal of Neurology Neurosurgery & Psychiatry article Medicine Myasthenia Gravis and Thymoma Open access 10 citations Clinical and imaging clues to the diagnosis and follow‐up of ptosis and ophthalmoparesis 2022 Journal of Cachexia Sarcopenia and Muscle article Medicine Ophthalmology and Eye Disorders Open access 14 citations IgG4 Autoantibodies in Organ-Specific Autoimmunopathies: Reviewing Class Switching, Antibody-Producing Cells, and Specific Immunotherapies 2022 Frontiers in Immunology article Medicine IgG4-Related and Inflammatory Diseases Open access 42 citations A bioassay for neuromuscular junction-restricted complement activation by myasthenia gravis acetylcholine receptor antibodies 2022 Journal of Neuroscience Methods article Medicine Myasthenia Gravis and Thymoma Open access 17 citations Advances and ongoing research in the treatment of autoimmune neuromuscular junction disorders 2022 The Lancet Neurology article Medicine Myasthenia Gravis and Thymoma Open access 115 citations Myasthenia gravis: do not forget the patient perspective 2021 Neuromuscular Disorders article Medicine Myasthenia Gravis and Thymoma Open access 33 citations Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial 2021 The Lancet Neurology article Medicine Myasthenia Gravis and Thymoma Open access cited by 7 patents 733 citations The feasibility of quantitative MRI of extra‐ocular muscles in myasthenia gravis and Graves' orbitopathy 2020 NMR in Biomedicine article Medicine Ophthalmology and Eye Disorders Open access 36 citations 1–20 of 22 Page 1 / 2 Next → References 0